Answers are grounded in this paper and cite their sources.
On average, patients with T2DM who have or are at risk for ASCVD report low levels of PA and have low measured cardiopulmonary fitness. This underscores the importance of continued efforts to close this therapeutic gap.
No takes yet. Share an insight, caveat, or question.
Jarvie et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: